Literature DB >> 2210067

A unified hypothesis for the complex genetics of HLA associations with IDDM.

G T Nepom1.   

Abstract

Our understanding of the role of HLA genes associated with insulin-dependent diabetes mellitus (IDDM) is in disarray, despite recent improvements in the definition of specific alleles and haplotypes. Some genes are highly associated with IDDM, other genes are associated with resistance to IDDM, and some highly associated susceptibility genes are markedly influenced by trans-associated synergistic effects (DR3/4 heterozygotes) or protective effects (DR2/4 heterozygotes). This plethora of genetic associations has spawned the notion that there are many contributing susceptibility genes, which, in turn, has led to the search for shared structural features among different genes on IDDM-associated haplotypes. From a more mechanistic point of view, however, the wide range of variable IDDM associations, with both cis- and trans-encoded protective and/or synergistic effects, suggests a different approach. This article proposes a hypothesis in which the different HLA associations with IDDM can be simply explained by a single unifying concept: a hierarchy of affinities determines the interaction between a diabetogenic peptide and different class II molecules, and an individual is susceptible to IDDM if the class II molecule in that individual with the highest affinity for such a peptide is a DQ beta susceptibility gene. The explicit formulation of this proposal and its genetic implications provide an explanation for HLA-encoded dominant "protection" and for some of the more subtle genetic observations related to cis and trans influences in IDDM susceptibility.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2210067     DOI: 10.2337/diab.39.10.1153

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  32 in total

Review 1.  Genetic predisposition to IDDM.

Authors:  S Caillat-Zucman; J F Bach
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

Review 2.  Immune mechanisms that regulate susceptibility to autoimmune type I diabetes.

Authors:  B Singh; T L Delovitch
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

Review 3.  Genetic bases of autoimmune hepatitis.

Authors:  Albert J Czaja; Derek G Doherty; Peter T Donaldson
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199

4.  HLA class II DR-DQ amino acids and insulin-dependent diabetes mellitus: application of the haplotype method.

Authors:  A M Valdes; S McWeeney; G Thomson
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

5.  Genetic predisposition and environmental factors leading to the development of insulin-dependent diabetes mellitus in Chilean children.

Authors:  F Perez-Bravo; E Carrasco; M D Gutierrez-Lopez; M T Martinez; G Lopez; M G de los Rios
Journal:  J Mol Med (Berl)       Date:  1996-02       Impact factor: 4.599

6.  Cell-surface MHC density profiling reveals instability of autoimmunity-associated HLA.

Authors:  Hiroko Miyadera; Jun Ohashi; Åke Lernmark; Toshio Kitamura; Katsushi Tokunaga
Journal:  J Clin Invest       Date:  2014-12-08       Impact factor: 14.808

7.  Promiscuous binding of proinsulin peptides to Type 1 diabetes-permissive and -protective HLA class II molecules.

Authors:  T P Astill; R J Ellis; S Arif; T I M Tree; M Peakman
Journal:  Diabetologia       Date:  2003-04-09       Impact factor: 10.122

8.  Genetic analysis of HLA class II alleles and susceptibility to type 1 (insulin-dependent) diabetes mellitus in Japanese subjects.

Authors:  T Awata; T Kuzuya; A Matsuda; Y Iwamoto; Y Kanazawa
Journal:  Diabetologia       Date:  1992-05       Impact factor: 10.122

9.  PD-1 deficiency reveals various tissue-specific autoimmunity by H-2b and dose-dependent requirement of H-2g7 for diabetes in NOD mice.

Authors:  Taku Yoshida; Fang Jiang; Tasuku Honjo; Taku Okazaki
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-25       Impact factor: 11.205

10.  Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with the HLA DQA1*0301-DQB1*0302 haplotype at clinical type 1 (insulin-dependent) diabetes mellitus before age 10 years, but not at onset between age 10 and 40 years. The Belgian Diabetes Registry.

Authors:  C L Vandewalle; T Decraene; F C Schuit; I H De Leeuw; D G Pipeleers; F K Gorus
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.